| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8650862 | American Heart Journal | 2018 | 31 Pages |
Abstract
AIM-HY INFORM is a prospective, open-label, randomized trial which aims to evaluate first- and second-line antihypertensive therapies for multiethnic populations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Omar MRCP, Joseph FRCP, John R. FESC, David PhD, James M. MD, Indranil FRCP, Luca MBBS, Mark PhD, Anthony M. FMedSci, Teck K. FRCP, Gregory Y.H. MD, Adrian P. PhD, Mellone N. PhD, Una FRCPI, Barry J. PhD, Carmel M. PhD, Sandosh FRCP, Manish MBBS,